JPRN-jRCTs031220136Recruiting未知
Standardization of Japanese cypress pollen antigen and development of diagnosis for Japanese cypress pollinosis using skin test - SJCYP
Okano Mitsuhiro0 sites50 target enrollmentStarted: June 15, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to < 60age old (—)
- Sex
- All
Inclusion Criteria
- •1. Japanese adults having serum IgE specific for Japanese cypress pollen equal or above class 2
- •2. Aged equal or more than 20 years old and less than 60 years old
- •3. Regardless of gender
- •4. Acquisition of written informed consent for participation on this clinical trial
- •5. Possible to visit hospital/clinic and follow
Exclusion Criteria
- •1. Subjects using drugs such as antihistamine which may affect results of skin test at examination day
- •2. Subjects having disease on application site of skin test
- •3. Subjects having experience of Japanese cedar-specific allergen immunotherapy
- •4. Subjects having severe asthma
- •5. Subjects having uncontrolled allergic diseases
- •6. Subjects having experience of anaphylaxis
- •7. Subjects having experience of hypersensitivity to adrenalin
- •8. Subjects having heart, liver, kidney or blood diseases or infection which may affect the outcome of examination
- •9. Subjects with pregnancy or breastfeeding
- •10. Subjects who are judged inappropriate to participate in the trial by investigator
Investigators
Similar Trials
Active, not recruiting
Phase 1
Biological standarization of pollen of Phleum pratense, Lolium perenne, Poa pratensis y Dactylis glomerata and its mixture to obtain extracts of these pollens with a potency provokes the same skin reaction in sensitive patients that the reaction the histamine produces in the subjects.Biological standarization for allergenic extracts in patients with hipersensibility to extractMedDRA version: 20.0Level: HLGTClassification code 10001708Term: Allergic conditionsSystem Organ Class: 10021428 - Immune system disordersEUCTR2019-002644-24-ESDiater, Laboratorio de Diagnóstico y Aplicaciones Terapéuticas S.A.120
Active, not recruiting
Not Applicable
Biological standardization of allergen extracts of pollen of Artemisa vulgaris and Platanus acerifolia and the acarus Dermatophagoides farinae in patients sensitized to themTreatment and diagnosis of allergy to Artemisa vulgaris, Platanus acerifolia and Dermatophagoides farinae.MedDRA version: 14.1Level: LLTClassification code 10036019Term: Pollen allergySystem Organ Class: 10021428 - Immune system disordersMedDRA version: 14.1Level: LLTClassification code 10066092Term: Acaridae allergySystem Organ Class: 10021428 - Immune system disordersMedDRA version: 14.1Level: PTClassification code 10048908Term: Seasonal allergySystem Organ Class: 10021428 - Immune system disordersEUCTR2012-000672-42-ESBial Industrial Farmacéutica S.A.
Active, not recruiting
Phase 1
Biological standardization of allergen extracts of pollen of Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense and Poa pratensis in patients sensitized to them.Biological standardization for allergenic extracts in patients with hipersensibility to extracts.EUCTR2014-001210-26-ESPROBELTE PHARMA S.A.63
Active, not recruiting
Not Applicable
To determine the minimum amount of Poa pratensis allergen extract producing a positive skin reaction.Allergy to Poa pratensis.MedDRA version: 14.0Level: LLTClassification code 10036019Term: Pollen allergySystem Organ Class: 10021428 - Immune system disordersEUCTR2010-023950-35-ESaboratorios Leti, S.L.Unipersonal
Active, not recruiting
Phase 1
Biological standardization of pollen of Phleum pratense, Olea europaea, mite extract Dermatophagoides pteronyssinus and animal allergen Felis domesticus.Biological standardization for allergenic extracts in patients with hipersensibility to extractsMedDRA version: 20.0Level: HLGTClassification code 10001708Term: Allergic conditionsSystem Organ Class: 10021428 - Immune system disordersEUCTR2012-005362-35-ESInstituto de Inmunología y Alergia INMUNAL SA100